These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 16267366)

  • 1. Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease.
    Owen CA
    Proc Am Thorac Soc; 2005; 2(4):373-85; discussion 394-5. PubMed ID: 16267366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease.
    Owen CA
    Int J Chron Obstruct Pulmon Dis; 2008; 3(2):253-68. PubMed ID: 18686734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease.
    MacNee W
    Proc Am Thorac Soc; 2005; 2(1):50-60. PubMed ID: 16113469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of chronic obstructive pulmonary disease.
    MacNee W
    Proc Am Thorac Soc; 2005; 2(4):258-66; discussion 290-1. PubMed ID: 16267346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatments for chronic obstructive pulmonary disease.
    Barnes PJ
    Ann Ist Super Sanita; 2003; 39(4):573-82. PubMed ID: 15098577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidants and COPD.
    MacNee W
    Curr Drug Targets Inflamm Allergy; 2005 Dec; 4(6):627-41. PubMed ID: 17305519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alveolar macrophages in chronic obstructive pulmonary disease (COPD).
    Barnes PJ
    Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL627-37. PubMed ID: 15579256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pathobiology of COPD].
    Pohl W
    Wien Med Wochenschr; 2005 Mar; 155(5-6):85-9. PubMed ID: 15884487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidants in asthma and in chronic obstructive pulmonary disease (COPD).
    Psarras S; Caramori G; Contoli M; Papadopoulos N; Papi A
    Curr Pharm Des; 2005; 11(16):2053-62. PubMed ID: 15974958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.
    Brassington K; Selemidis S; Bozinovski S; Vlahos R
    Clin Sci (Lond); 2019 Apr; 133(7):885-904. PubMed ID: 30979844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant therapeutic targets in COPD.
    Rahman I; Kilty I
    Curr Drug Targets; 2006 Jun; 7(6):707-20. PubMed ID: 16787173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidants/antioxidants and chronic obstructive pulmonary disease: pathogenesis to therapy.
    MacNee W
    Novartis Found Symp; 2001; 234():169-85; discussion 185-8. PubMed ID: 11199095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets.
    Rahman I
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):291-315. PubMed ID: 14561194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease.
    Biswas S; Hwang JW; Kirkham PA; Rahman I
    Curr Med Chem; 2013; 20(12):1496-530. PubMed ID: 22963552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future therapeutic treatment of COPD: struggle between oxidants and cytokines.
    de Boer WI; Yao H; Rahman I
    Int J Chron Obstruct Pulmon Dis; 2007; 2(3):205-28. PubMed ID: 18229560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.
    Tse HN; Tseng CZ
    Int J Chron Obstruct Pulmon Dis; 2014; 9():825-36. PubMed ID: 25125976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease?
    MacNee W; Rahman I
    Trends Mol Med; 2001 Feb; 7(2):55-62. PubMed ID: 11286755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen-rich saline inhibits tobacco smoke-induced chronic obstructive pulmonary disease by alleviating airway inflammation and mucus hypersecretion in rats.
    Liu Z; Geng W; Jiang C; Zhao S; Liu Y; Zhang Y; Qin S; Li C; Zhang X; Si Y
    Exp Biol Med (Maywood); 2017 Sep; 242(15):1534-1541. PubMed ID: 28795606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of oxidative stress in the pathogenesis of COPD: implications for therapy.
    Rahman I
    Treat Respir Med; 2005; 4(3):175-200. PubMed ID: 15987234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis of chronic obstructive pulmonary disease].
    Vogelmeier C; Koczulla R; Fehrenbach H; Bals R
    Internist (Berl); 2006 Sep; 47(9):885-6, 888-90, 892-4. PubMed ID: 16845536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.